Cargando…
‘Earlier than Early’ Detection of Breast Cancer in Israeli BRCA Mutation Carriers Applying AI-Based Analysis to Consecutive MRI Scans
SIMPLE SUMMARY: Women who have a genetic mutation of BRCA1 or BRCA2 are at a significantly higher risk for developing breast cancer. Early detection is crucial for an improved prognosis, therefore they are offered an intensive follow-up program, including a yearly MRI scan. Although MRI is the most...
Autores principales: | Anaby, Debbie, Shavin, David, Zimmerman-Moreno, Gali, Nissan, Noam, Friedman, Eitan, Sklair-Levy, Miri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296520/ https://www.ncbi.nlm.nih.gov/pubmed/37370730 http://dx.doi.org/10.3390/cancers15123120 |
Ejemplares similares
-
Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?
por: Bernstein-Molho, Rinat, et al.
Publicado: (2019) -
Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers
por: Faermann, Renata, et al.
Publicado: (2022) -
COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases
por: Faermann, Renata, et al.
Publicado: (2021) -
Breast MRI during pregnancy and lactation: clinical challenges and technical advances
por: Nissan, Noam, et al.
Publicado: (2022) -
Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates
por: Helpman, Limor, et al.
Publicado: (2017)